IP Library Granted Patent US 8,627,957
Granted Patent B2
US 8,627,957 · App. 13/691,766 · Granted Jan 14, 2014

Sealable secondary packaging for pharmaceutical product blister pack

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,627,957
App. No.
13/691,766
Granted
Jan 14, 2014
Kind
B2
Abstract

A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).

Claims (32)

1. A pharmaceutical product supply, comprising:

a first panel and a second panel, wherein said first panel comprises a first section and a second section, wherein said first section adjoins said second panel, and wherein said second section is folded onto said first section when said pharmaceutical product supply is in a first configuration;

a pharmaceutical product receiver associated with said second panel and comprising a plurality of receptacles;

pharmaceutical product enclosed within at least one of said plurality of receptacles of said pharmaceutical product receiver; and

adhesive between said first section of said first panel and said second section of said first panel when said pharmaceutical product supply is in said first configuration;

wherein said first panel is movable between an open position and a closed position relative to said second panel to provide access to said pharmaceutical product receiver when said pharmaceutical product supply is in said first configuration, and wherein said second section of said first panel is disposed between said second panel and said first section of said first panel when said first panel is in said closed position and when said pharmaceutical product supply is in said first configuration; and

wherein said pharmaceutical product supply is disposable and retained in a second configuration where said second section of said first panel is moved away from said first section of said first panel, where said first section of said first panel is adhered to at least a first side of said second panel, and where said second section of said first panel is adhered to at least a second side of said second panel, wherein said first side of said second panel and said second side of said second panel are oppositely disposed to one another.

2. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product receiver is incorporated on said first side of said second panel, wherein said second section of said first panel comprises a release liner that is attached to said first section of said first panel at a location that is spaced from an intersection between said first panel and said second panel, and wherein a surface of said release liner and a surface of said first section of said first panel that face each other with said pharmaceutical product supply being in said first configuration each comprise said adhesive.

3. The pharmaceutical product supply of claim 1 , wherein said second section of said first panel comprises a release liner that is attached to said first section of said first panel at a location that is spaced from an intersection between said first panel and said second panel, wherein a surface of said release liner and a surface of said first section of said first panel that face each other with said pharmaceutical product supply being in said first configuration each comprise said adhesive, and wherein said first side of said second panel comprises an opening to an internal storage area in which said pharmaceutical product receiver is disposed.

4. The pharmaceutical product supply of claim 3 , further comprising a second pharmaceutical product receiver within said internal storage area.

5. The pharmaceutical product supply of claim 3 , wherein a first end of said first section of said first panel is at said intersection between said first panel and said second panel, and wherein said release liner is attached to a second end of said first section of said first panel that is opposite of said first end.

6. The pharmaceutical product supply of claim 3 , wherein at least one of said first section of said first panel and said release liner is also adhered to an end section of said second panel when said pharmaceutical product supply is in said second configuration.

7. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product receiver is incorporated on said first side of said second panel, wherein said second section of said first panel is attached to said first section of said first panel at a location that is spaced from an intersection between said first panel section and said second panel, wherein a surface of said first section of said first panel and a surface of said second section of said first panel that face each other when said pharmaceutical product supply is in said first configuration each comprise said adhesive, said pharmaceutical product supply further comprising:

at least one release liner between said surface of said first section of said first panel and said second section of said first panel that face each other when said pharmaceutical product supply is in said first configuration.

8. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product receiver is incorporated on said first side of said second panel, wherein said first side of said second panel comprises an opening to an internal storage area in which said pharmaceutical product receiver is disposed, wherein said second section of said first panel is attached to said first section of said first panel at a location that is spaced from an intersection between said first section of said first panel and said second panel, wherein a surface of said first section and a surface of said second section of said first panel that face each other when said pharmaceutical product supply is in said first configuration each comprise said adhesive, said pharmaceutical product supply further comprising:

at least one release liner between said surface of said first section of said first panel and said second section of said first panel that face each other when said pharmaceutical product supply is in said first configuration.

9. The pharmaceutical product supply of claim 8 , further comprising a second pharmaceutical product receiver within said internal storage area.

10. The pharmaceutical product supply of claim 8 , wherein a first end of said first section of said first panel is at said intersection between said first panel and said second panel, and wherein said second section of said first panel is attached to a second end of said first section of said first panel that is opposite of said first end.

11. The pharmaceutical product supply of claim 8 , wherein at least one of said first section of said first panel and said second section of said first panel is also adhered to an end section of said second panel when said pharmaceutical product supply is in said second configuration.

12. The pharmaceutical product supply of claim 1 , wherein each said receptacle comprises an opening, each receptacle of said plurality of receptacles that includes said pharmaceutical product having a corresponding covering over its corresponding said opening, and wherein no said corresponding covering for any of said plurality of receptacles is accessible through any operable access on said first panel when said pharmaceutical product supply is disposed and retained in said second configuration.

13. A pharmaceutical product supply, comprising:

first panel and a second panel, wherein said first panel comprises a surface having an adhesive, wherein a release liner is attached to said first panel at a location that is spaced from an intersection between said first panel and said second panel, and wherein said release liner comprises a surface having an adhesive;

a pharmaceutical product receiver associated with said second panel and comprising a plurality of receptacles; and

pharmaceutical product enclosed within at least one of said plurality of receptacles of said pharmaceutical product receiver;

wherein said first panel is movable between an open position and a closed position relative to said second panel to provide access to said pharmaceutical product receiver when said pharmaceutical product supply is in a first configuration where said surface of said release liner having said adhesive is positioned over said surface of said first panel having said adhesive; and

wherein said pharmaceutical product supply is disposable and retained in a second configuration where said release liner is moved away from said first panel, where said first panel is adhered to at least a first side of said second panel, and where said release liner is adhered to at least a second side of said second panel, wherein said first side of said second panel and said second side of said second panel are oppositely disposed to one another.

14. The pharmaceutical product supply of claim 13 , wherein said pharmaceutical product receiver is incorporated on said first side of said second panel.

15. The pharmaceutical product supply of claim 13 , wherein said first side of said second panel comprises an opening to an internal storage area in which said pharmaceutical product receiver is disposed.

16. The pharmaceutical product supply of claim 15 , further comprising a second pharmaceutical product receiver within said internal storage area.

17. The pharmaceutical product supply of claim 13 , wherein a first end of said first panel is at said intersection between said first panel and said second panel, and wherein said release liner is attached to a second end of said first panel that is opposite of said first end.

18. The pharmaceutical product supply of claim 13 , wherein at least one of said first panel and said release liner is also adhered to an end section of said second panel when said pharmaceutical product supply is in said second configuration.

19. The pharmaceutical product supply of claim 13 , wherein each said receptacle comprises an opening, each receptacle of said plurality of receptacles that includes said pharmaceutical product having a corresponding covering over its corresponding said opening, wherein no said corresponding covering for any of said plurality of receptacles is accessible through any openable access on said first panel when said pharmaceutical product supply is disposed and retained in said second configuration.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →
CHANGE OF LEGAL ENTITY Recorded Jul 29, 2015
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 036213/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2015
From: ZIEMBA, ROBERT J.; ORTENZI, VERNON D.
To: MALLINCKRODT INC.
Reel/Frame 036206/0388 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →